https://preview.xbpnews.com/3-stocks-worth-monitoring-this-month-cellectis-clls-alterity-therapeutics-athe-cardiol-therapeutics-crdl Stocks Telegraph en 2026-05-15 3 Stocks Worth Monitoring This Month: Cellectis (CLLS), Alterity Therapeutics (ATHE), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-making-headlines-today-cardiol-therapeutics-crdl-kala-bio-kala-pelthos-therapeutics-pths Stocks Telegraph en 2026-05-15 3 Stocks Making Headlines Today: Cardiol Therapeutics (CRDL), Kala Bio (KALA), Pelthos Therapeutics (PTHS) https://preview.xbpnews.com/3-stocks-that-could-surprise-the-market-polypid-pypd-cardiol-therapeutics-crdl-nyxoah-nyxh Stocks Telegraph en 2026-05-15 3 Stocks That Could Surprise the Market: Polypid (PYPD), Cardiol Therapeutics (CRDL), Nyxoah (NYXH) https://preview.xbpnews.com/wix-com-ltd-wix-assigned-sector-perform-rating-potential-for-upside-amidst-market-volatility Stocks Telegraph en 2026-05-14 Wix.com Ltd. (WIX) Assigned Sector Perform Rating; Potential for Upside Amidst Market Volatility https://preview.xbpnews.com/tango-therapeutics-inc-tngx-jefferies-assigns-hold-rating-amid-market-volatility Stocks Telegraph en 2026-05-14 Tango Therapeutics, Inc. (TNGX): Jefferies Assigns ‘Hold’ Rating Amid Market Volatility https://preview.xbpnews.com/sangoma-technologies-corporation-sang-analyst-downgrade-to-hold-amid-price-decline Stocks Telegraph en 2026-05-14 Sangoma Technologies Corporation (SANG): Analyst Downgrade to Hold amid Price Decline https://preview.xbpnews.com/everpure-inc-p-receives-neutral-rating-from-citigroup-amidst-steady-performance Stocks Telegraph en 2026-05-14 Everpure, Inc. (P) Receives Neutral Rating from Citigroup Amidst Steady Performance https://preview.xbpnews.com/doximity-inc-docs-receives-neutral-rating-from-baird-amid-continued-volatility Stocks Telegraph en 2026-05-14 Doximity, Inc. (DOCS) Receives Neutral Rating from Baird Amid Continued Volatility https://preview.xbpnews.com/autohome-inc-athm-receives-hold-rating-from-hsbc-reflecting-limited-upside-potential Stocks Telegraph en 2026-05-14 Autohome Inc. (ATHM) Receives ‘Hold’ Rating from HSBC, Reflecting Limited Upside Potential https://preview.xbpnews.com/an2-therapeutics-inc-antx-ratings-upgrade-growth-potential-ahead Stocks Telegraph en 2026-05-14 AN2 Therapeutics, Inc. (ANTX) Ratings Upgrade: Growth Potential Ahead https://preview.xbpnews.com/assurant-inc-aiz-gains-overweight-rating-strong-analyst-confidence-with-upside-potential Stocks Telegraph en 2026-05-14 Assurant, Inc. (AIZ) Gains Overweight Rating: Strong Analyst Confidence with Upside Potential https://preview.xbpnews.com/wix-com-ltd-wix-citigroup-issues-neutral-rating-amidst-volatile-trading-environment Stocks Telegraph en 2026-05-14 Wix.com Ltd. (WIX): Citigroup Issues Neutral Rating Amidst Volatile Trading Environment https://preview.xbpnews.com/whirlpool-corporation-whr-goldman-sachs-assigns-neutral-outlook-with-price-target-of-53 Stocks Telegraph en 2026-05-14 Whirlpool Corporation (WHR): Goldman Sachs Assigns Neutral Outlook with Price Target of $53 https://preview.xbpnews.com/staar-surgical-company-staa-receives-outperform-rating-with-significant-upside-potential Stocks Telegraph en 2026-05-14 STAAR Surgical Company (STAA) Receives Outperform Rating with Significant Upside Potential https://preview.xbpnews.com/starbucks-corporation-sbux-td-cowen-upgrades-to-buy-with-price-target-of-120 Stocks Telegraph en 2026-05-14 Starbucks Corporation (SBUX): TD Cowen Upgrades to Buy with Price Target of $120 https://preview.xbpnews.com/mid-america-apartment-communities-inc-maa-downgraded-to-sector-underperform-analysts-signal-caution Stocks Telegraph en 2026-05-14 Mid-America Apartment Communities, Inc. (MAA) Downgraded to Sector Underperform: Analysts Signal Caution https://preview.xbpnews.com/doximity-inc-docs-receives-equal-weight-rating-from-wells-fargo-amid-market-fluctuations Stocks Telegraph en 2026-05-14 Doximity, Inc. (DOCS) Receives Equal-Weight Rating from Wells Fargo Amid Market Fluctuations https://preview.xbpnews.com/camden-property-trust-cpt-receives-sector-underperform-rating-from-scotiabank-price-target-set-at-95 Stocks Telegraph en 2026-05-14 Camden Property Trust (CPT) Receives Sector Underperform Rating from Scotiabank, Price Target Set at $95 https://preview.xbpnews.com/compass-minerals-international-inc-cmp-neutral-rating-from-jp-morgan-highlights-limited-upside Stocks Telegraph en 2026-05-14 Compass Minerals International, Inc. (CMP): Neutral Rating from JP Morgan Highlights Limited Upside https://preview.xbpnews.com/commercial-metals-company-cmc-analyst-upgrade-signals-strong-growth-potential-ahead Stocks Telegraph en 2026-05-14 Commercial Metals Company (CMC): Analyst Upgrade Signals Strong Growth Potential Ahead https://preview.xbpnews.com/the-cheesecake-factory-incorporated-cake-neutral-rating-with-upside-potential Stocks Telegraph en 2026-05-14 The Cheesecake Factory Incorporated (CAKE): Neutral Rating with Upside Potential https://preview.xbpnews.com/amphastar-pharmaceuticals-inc-amph-wells-fargo-assigns-equal-weight-rating-amid-sluggish-performance Stocks Telegraph en 2026-05-14 Amphastar Pharmaceuticals, Inc. (AMPH): Wells Fargo Assigns Equal-Weight Rating Amid Sluggish Performance https://preview.xbpnews.com/3-stocks-showing-bullish-signals-collplant-biotechnologies-clgn-abvc-biopharma-abvc-cardiol-therapeutics-crdl Stocks Telegraph en 2026-05-14 3 Stocks Showing Bullish Signals: CollPlant Biotechnologies (CLGN), ABVC BioPharma (ABVC), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-that-could-see-momentum-passage-bio-pasg-cardiol-therapeutics-crdl-scisparc-sprc Stocks Telegraph en 2026-05-14 3 Stocks That Could See Momentum: Passage Bio (PASG), Cardiol Therapeutics (CRDL), SciSparc (SPRC) https://preview.xbpnews.com/3-stocks-that-could-stand-out-cardiol-therapeutics-crdl-immuron-imrn-retractable-technologies-rvp Stocks Telegraph en 2026-05-14 3 Stocks That Could Stand Out: Cardiol Therapeutics (CRDL), Immuron (IMRN), Retractable Technologies (RVP) https://preview.xbpnews.com/zebra-technologies-corporation-zbra-receives-overweight-rating-signaling-strong-upside-potential Stocks Telegraph en 2026-05-13 Zebra Technologies Corporation (ZBRA) Receives Overweight Rating, Signaling Strong Upside Potential https://preview.xbpnews.com/under-armour-inc-uaa-receives-hold-rating-from-stifel-analysts-eye-a-price-target-of-6 Stocks Telegraph en 2026-05-13 Under Armour, Inc. (UAA) Receives ‘Hold’ Rating from Stifel; Analysts Eye a Price Target of $6 https://preview.xbpnews.com/sensata-technologies-holding-plc-st-analysts-initiate-buy-rating-amidst-strong-upside-potential Stocks Telegraph en 2026-05-13 Sensata Technologies Holding plc (ST): Analysts Initiate Buy Rating Amidst Strong Upside Potential https://preview.xbpnews.com/select-medical-holdings-corporation-sem-receives-neutral-rating-amid-mixed-earnings-outlook Stocks Telegraph en 2026-05-13 Select Medical Holdings Corporation (SEM) Receives Neutral Rating Amid Mixed Earnings Outlook https://preview.xbpnews.com/integer-holdings-corporation-itgr-receives-outperform-rating-with-strong-upside-potential Stocks Telegraph en 2026-05-13 Integer Holdings Corporation (ITGR) Receives Outperform Rating with Strong Upside Potential https://preview.xbpnews.com/zoominfo-technologies-inc-gtm-downgraded-to-underperform-by-mizuho-investors-take-note Stocks Telegraph en 2026-05-13 ZoomInfo Technologies Inc. (GTM) Downgraded to Underperform by Mizuho: Investors Take Note https://preview.xbpnews.com/avnet-inc-avt-receives-neutral-rating-from-b-of-a-securities-amidst-mixed-market-sentiment Stocks Telegraph en 2026-05-13 Avnet, Inc. (AVT) Receives Neutral Rating from B of A Securities Amidst Mixed Market Sentiment https://preview.xbpnews.com/arrow-electronics-inc-arw-receives-neutral-rating-amid-positive-earnings-surprise Stocks Telegraph en 2026-05-13 Arrow Electronics, Inc. (ARW) Receives Neutral Rating Amid Positive Earnings Surprise https://preview.xbpnews.com/akamai-technologies-inc-akam-analyst-upgrades-to-buy-with-price-target-of-175 Stocks Telegraph en 2026-05-13 Akamai Technologies, Inc. (AKAM): Analyst Upgrades to Buy with Price Target of $175